DNA Methylation Recovery and Its Implications in Cancer Treatment
Author Information
Author(s): Wong Chun-Ming, Wong Carmen Chak-Lui, Ng Yeung-Lam, Au Sandy Leung-Kuen Ko, Ng Frankie Chi-Fat, Oi-Lin Irene
Primary Institution: University of Hong Kong
Hypothesis
Can mammalian cells recover DNA methylation after demethylation treatment, and what role do histone modifications play in this process?
Conclusion
Mammalian cells possess a DNA methylation recovery system mediated by DNMT1, which is associated with transcriptional repressive histone modifications.
Supporting Evidence
- DNA methylation recovery was observed in multiple cancer cell lines.
- DNMT1 was essential for the recovery of DNA methylation after demethylation treatment.
- H3K9 and H3K27 tri-methylations were associated with the DNA methylation recovery process.
- 5-Aza-dC treatment led to incomplete restoration of DNA methylation.
- Residual gene expression was detected in 5-Aza-dC-recovered cells.
Takeaway
When cancer cells are treated with a drug that removes DNA methylation, they can sometimes put the methylation back, which can make it harder to treat cancer.
Methodology
The study used cancer cell lines treated with 5-Aza-dC to induce demethylation and analyzed the recovery of DNA methylation and associated histone modifications.
Potential Biases
Potential bias in the selection of cell lines and experimental conditions.
Limitations
The study primarily focused on specific cell lines, which may limit the generalizability of the findings.
Participant Demographics
Human cancer cell lines, including SMMC-7721, HCT116, and HeLa.
Statistical Information
P-Value
0.0010
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website